We´re doomed we´re saved - Die Biorevolution
We’re doomed we’re saved mit Andreas Horchler und Louise von Stechow – Vater und Tochter, er Journalist, sie Biologin, sprechen über die Technologien der Biorevolution. Können Gentechnik, Synthetische Biologie und Künstliche Intelligenz die Menschheit vor Krankheit, Klimawandel und Überbevölkerung retten, oder sind diese Technologien der erste Schritt ihres Untergangs? Mehr unter https://science-tales.com/ Inhalt und Bearbeitung: Louise von Stechow und Andreas Horchler Bild: Kelly Sikkema via Unsplash
- Website
- https://science-tales.com/
- Description
- We’re doomed we’re saved mit Andreas Horchler und Louise von Stechow – Vater und Tochter, er Journalist, sie Biologin, sprechen über die Technologien der Biorevolution. Können Gentechnik, Synthetische Biologie und Künstliche Intelligenz die Menschheit vor Krankheit, Klimawandel und Überbevölkerung retten, oder sind diese Technologien der erste Schritt ihres Untergangs? Mehr unter https://science-tales.com/ Inhalt und Bearbeitung: Louise von Stechow und Andreas Horchler Bild: Kelly Sikkema via Unsplash
- Language
- 🇩🇪 German
- last modified
- 2025-02-22 12:23
- last episode published
- 2025-02-03 06:00
- publication frequency
- 30.47 days
- Contributors
- Louise von Stechow
- Author
- Louise von Stechow
- Owner
- Explicit
- false
- Number of Episodes
- 31
- Rss-Feeds
- Detail page
- Categories
- Life Sciences Natural Sciences Science & Medicine
Recommendations
Episodes
| Date | Title & Description | Contributors |
|---|---|---|
| 2025-02-03 | In some respects, 2024 has been a record year for AI in biotech, with the $1 billion founding of the antibody-centered biotech company Xaira and the awarding of the Nobel Prize in Chemistry to DeepMind researchers Demis Hassabis, John Jumper, and David... |
|
| 2025-01-03 | 2025: For millions of people, the new year starts with the self-promise to improve, to quit smoking, alcohol, to get in shape, to stay young and attractive, to basically create and become a new me. While traditionally new year vows meant to relinquish,... |
|
| 2024-12-02 | Modern humans are stressed creatures: overloaded schedules, constantly “on-call,” and social media haunting us into the late night. Part of this stress is maladaptive responses that date back to human history when stressors were about life and death an... |
|
| 2024-11-01 | Science can be complex and difficult to grasp, yet public understanding is crucial for navigating issues like disease risk, climate change, and pandemics. Clear, engaging science communication can help prevent misinformation and conspiracy theories, of... |
|
| 2024-10-01 | In the expensive and failure-prone process of drug development, artificial intelligence (AI) can serve both as an efficiency tool and as a creativity tool. Increased efficiency means shorter timelines, reduced investment, and earlier insights into succ... |
|
| 2024-09-02 | How will the medicine of the future look? Healthcare and medicine are on the verge of transformative change, driven by new technologies such as artificial intelligence, telemedicine, and wearable devices. Alongside the technologization and virtualizati... |
|
| 2024-08-02 | Some 36 months after the release of ChatGPT, the verdict is still out on the role that large language models (LLMs) will play in biotech, pharma, and medicine. On paper, the range of tasks that LLMs can perform in biomedical research and healthcare is ... |
|
| 2024-07-02 | Rare or orphan diseases affect only a small percentage of the population and often lack effective treatments. While rare individually, in total, more than 350 million people worldwide live with rare diseases. Many of these are very hard to diagnose, le... |
|
| 2024-06-03 | When we think about revolutions, we think of systemic changes in politics, economics, and lifestyles. Revolutions transform how we live, work, interact, and communicate. In the past, political uprisings and new technologies, from the steam engine to th... |
|
| 2024-05-03 | Polygenic risk scores (PRS), put simply, look at gene variants across the human genome in order to determine an individual's risk of getting a disease, from different types of cancer to type II diabetes. PRS could complement current risk prediction mod... |
|